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Background
The mite Dermatophagoides pteronyssinus is an important
source of allergens and a major risk factor for allergic rhini-
tis and asthma. A more effective and safe way for allergen
specific immunotherapy could be using recombinant aller-
gens or their derivatives, such as hybrid molecules. This
study was aimed to evaluate the immune response induced
in mice by a hybrid recombinant protein, harboring several
segments of major allergens of D. pteronyssinus.
Methods
We engineered a fusion protein called DPx4 assembling
segments of four allergens of D. pteronyssinus in a single
molecule. Three 8 female BALB/c mice groups were
immunized on days 0, 7, 14 and 21 as follows: group 1
with 10 ug of DPx4, group 2 with 20 ug D. pteronyssi-
nus extract and group 3 with PBS, antigens and PBS
were adsorbed to Al(OH)3. After immunization each
animal was challenged four times intranasally. Total IgE,
IgG2a and IgG1 levels were determined by ELISA. Bron-
chial hyperreactivity was evaluated by methacholine
challenge and measurement of means enhanced pause
(Penh). Mucus production in lung was evaluated with
periodic acid-Schiff (PAS) and cellular infiltrate by
hematoxylin-eosin staining.
Results
Animals treated with DPx4 showed significantly lower
total IgE and IgG 1 levels compared with mice treated
with extract, while the IgG2a levels were higher but not
statistically significant. Administration of DPx4 induced
lower, but not statistically significant, bronchial hyper-
reactivity than that induced by administration of
D. pteronyssinus. Treatment with DPx4 induced signifi-
cantly lower inflammation around the peribronchial and
perivascular zones than treatment with extract. The PAS
staining revealed goblet cell hyperplasia and mucus
hypersecretion in the bronchi of mice treated with
D. pteronyssinus extract but not in mice treated with
DPx4.
Conclusions
The administration of DPx4 in a mice model of asthma
induced a less bronchial inflammatory immune response
than the mite extract, suggesting that it has potential
value for the development of a mite allergen vaccine.
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